| 000 | 01745 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513225836.0 | ||
| 264 | 0 | _c20010301 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a1524-4571 | ||
| 024 | 7 |
_a10.1161/01.res.88.1.97 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZieman, S J | |
| 245 | 0 | 0 |
_aUpregulation of the nitric oxide-cGMP pathway in aged myocardium: physiological response to l-arginine. _h[electronic resource] |
| 260 |
_bCirculation research _cJan 2001 |
||
| 300 |
_a97-102 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAging _xphysiology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArginine _xpharmacology |
| 650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xmetabolism |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type III |
| 650 | 0 | 4 |
_aNitroprusside _xpharmacology |
| 650 | 0 | 4 |
_aOxadiazoles _xpharmacology |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aGerstenblith, G | |
| 700 | 1 | _aLakatta, E G | |
| 700 | 1 | _aRosas, G O | |
| 700 | 1 | _aVandegaer, K | |
| 700 | 1 | _aRicker, K M | |
| 700 | 1 | _aHare, J M | |
| 773 | 0 |
_tCirculation research _gvol. 88 _gno. 1 _gp. 97-102 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.res.88.1.97 _zAvailable from publisher's website |
| 999 |
_c11079544 _d11079544 |
||